Position in ABCL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,478,409
+$1,398,635 QoQ
Shares Held
315,721
+2.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ABCL ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,478,409 | 315,721 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,079,774 | 309,391 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,072,057 | 313,467 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,655,991 | 329,223 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,245,734 | 363,188 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $782,478 | 350,887 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $333,354 | 113,773 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $295,497 | 113,653 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $932,003 | 314,866 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,165,867 | 257,366 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,462,582 | 256,144 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,174,370 | 255,298 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,625,814 | 251,674 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,403,631 | 2,175,548 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,943,906 | 2,067,513 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,633,598 | 1,985,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,552,348 | 1,929,798 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,976,403 | 202,708 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,886,712 | 201,868 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $634,546 | 31,664 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,372,236 | 198,738 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,640,436 | 195,537 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,649,865 | 190,106 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||